Greenwich LifeSciences, Inc.
GLSI · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $136 | $121 | $126 | $148 |
| - Cash | $4 | $3 | $3 | $4 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $132 | $118 | $123 | $144 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | – |
| EBITDA | -$4 | -$4 | -$3 | -$8 |
| % Margin | – | – | – | – |
| Net Income | -$4 | -$4 | -$3 | -$8 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.3 | -0.3 | -0.25 | -0.61 |
| % Growth | 0% | -20% | 59% | – |
| Operating Cash Flow | -$3 | -$2 | -$2 | -$2 |
| Capital Expenditures | $0 | $0 | $0 | -$0 |
| Free Cash Flow | -$3 | -$2 | -$2 | -$2 |